Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine

R Cooper-Kazaz, A Cohen, B Lerer - Journal of clinical …, 2010 - journals.lww.com
DISCUSSION Cholesterol levels, as assessed before randomization, were negatively
related to physical aggression during the 4-week baseline period. There was also a …
被引用次数：4 相关文章

[引用][C] Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine

R Cooper-Kazaz, A Cohen… - Journal of clinical …, 2010 - pubmed.ncbi.nlm.nih.gov
Noradrenergic adverse effects due to combined treatment with reboxetine and
triiodothyronine Noradrenergic adverse effects due to combined treatment with reboxetine …

[引用][C] Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine.

R Cooper-Kazaz, A Cohen, B Lerer - Journal of Clinical …, 2010 - europepmc.org
Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

[引用][C] Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine

R Cooper-Kazaz, A Cohen, B Lerer - Journal of Clinical …, 2010 - hero.epa.gov
Noradrenergic adverse effects due to combined treatment with reboxetine and
triiodothyronine | Health & Environmental Research Online (HERO) | US EPA Jump to main …

[引用][C] Noradrenergic Adverse Effects Due to Combined Treatment With Reboxetine and Triiodothyronine

R COOPER-KAZAZ, A COHEN… - Journal of clinical …, 2010 - Lippincott Williams & Wilkins